Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer
Anticancer Research · 2023
DOI: 10.21873/anticanres.16210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Nobumitsu Ikeuchi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan.
- Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan hinoue@fukuoka-u.ac.jp.
Zitieren
APA
Ikeuchi, N., Igata, F., Kinoshita, E., Kawabata, T., Tan, I., Osaki, Y., Otsuka, R., On, R., Ikeda, T., Nakao, A., Sasaki, T., Aoyama, T., Hirano, R., Harada, T., Ebi, N., Fujita, M., & Inoue, H. (2023). Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.16210
Vancouver
Ikeuchi N, Igata F, Kinoshita E, Kawabata T, Tan I, Osaki Y, et al. Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer. Anticancer Research. 2023. doi:10.21873/anticanres.16210
BibTeX
@article{Ikeuchi2023,
author = {Ikeuchi, Nobumitsu and Igata, Fumiyasu and Kinoshita, Eriko and Kawabata, Toshiaki and Tan, Ibun and Osaki, Yusuke and Otsuka, Rikako and On, Rintaro and Ikeda, Takato and Nakao, Akira and Sasaki, Tomoya and Aoyama, Takashi and Hirano, Ryosuke and Harada, Taishi and Ebi, Noriyuki and Fujita, Masaki and Inoue, Hiroyuki},
title = {Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16210}
}
EUVIMED